Heart failure Trials in Shijiazhuang, China
Conditions / Heart failure / Shijiazhuang, China
Clinical trials for Heart failure investigate a range of treatment strategies and patient populations.
16 total trials for this combination
Showing top 10 of 16 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03579914 | Effect of Intravenous Metoprolol Combining RIC on Myocardial Protection in STEMI Patients | COMPLETED | NA |
| NCT06935370 | A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart | RECRUITING | — |
| NCT01612260 | Shensong Yangxin Capsule in the Treatment of Heart Failure Complicated With Ventricular Premature Beat | UNKNOWN | PHASE4 |
| NCT07292896 | A Multicenter Study on the Normal Reference Range and Clinical Significance of the Right Atrioventricular Coupling Index Assessed by Artificial Intelligence-Based Three-Dimensional Echocardiography | NOT_YET_RECRUITING | — |
| NCT05375110 | NoYA RAISE Trial II (Radiofrequency Ablation-Based Interatrial Shunt for Heart Failure) | UNKNOWN | NA |
| NCT03297164 | Incidence Rate of Heart Failure After Acute Myocardial Infarction With Optimal Treatment | COMPLETED | — |
| NCT06424288 | A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure | RECRUITING | — |
| NCT05636176 | A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation | RECRUITING | PHASE3 |
| NCT01877915 | A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure | COMPLETED | PHASE3 |
| NCT04435626 | Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40% | COMPLETED | PHASE3 |